FindTrial
Sign In

Analysis of Factors correlated with PSMA PET Imaging of Prostate Cancer Based on Pathological Characteristics

Analysis of Factors correlated with PSMA PET Imaging of Prostate Cancer Based on Pathological Characteristics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124746
Enrollment
Unknown
Registered
2026-05-17
Start date
2026-04-22
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:pathological results
Index test:PSMA PET examination

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed with prostate cancer and underwent radical prostatectomy at our hospital. 2.The patient underwent 18F-PSMA-1007 PET/CT or PET/MR examination within one week before the operation.

Exclusion criteria

Exclusion criteria: 1. The patient did not undergo 18F-PSMA-1007 PET/CT or PET/MR examination, or the image quality was not satisfactory for analysis; 2.The patient did not receive radical prostatectomy treatment at our hospital.

Design outcomes

Primary

MeasureTime frame
Tumour SUVmax value;Metabolic volume;Accuracy;Specificity;—

Countries

China

Contacts

Public ContactLiu Shitong

Zhejiang Cancer Hospital

591954357@qq.com+86 571 8812 2331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026